Antimicrobial Agents Practice Questions

Q: A patient with a severe penicillin allergy requires treatment for syphilis. Which alternative antibiotic should be considered?

Doxycycline. ***Doxycycline*** - **Doxycycline** is the recommended alternative for treating **syphilis** in patients with a **severe penicillin allergy**. - It is an effective **tetracycline antibiotic** that inhibits protein synthesis in *Treponema pallidum*. - Preferred over cephalosporins in severe allergies due to **no cross-reactivity** with penicillin. *Amoxicillin* - **Amoxicillin** is a **penicillin-class antibiotic** and would be contraindicated in a patient with a severe penicillin allergy due to the risk of allergic reaction. - It works by inhibiting bacterial cell wall synthesis, similar to penicillin. *Ceftriaxone* - **Ceftriaxone** is a **third-generation cephalosporin**, which has a low but present risk of **cross-reactivity** (approximately 1-3%) with penicillin in patients with severe penicillin allergies. - While sometimes used as an alternative in **non-severe** allergies, **doxycycline** is preferred in cases of **severe allergy** due to its lack of cross-reactivity. *Vancomycin* - **Vancomycin** is an antibiotic primarily used for **Gram-positive bacterial infections**, particularly **MRSA**, and is not effective against *Treponema pallidum*. - It works by inhibiting cell wall synthesis, but its spectrum of activity does not cover syphilis effectively.

Q: A patient presents with multidrug-resistant tuberculosis. Which drug, acting as an ATP synthase inhibitor, would be the most appropriate for treatment?

Bedaquiline. ***Bedaquiline*** - Bedaquiline is a diarylquinoline antimycobacterial agent that specifically inhibits **mycobacterial ATP synthase**, a crucial enzyme for energy production in *M. tuberculosis*. - It is a **novel drug approved for multidrug-resistant tuberculosis (MDR-TB)** due to its unique mechanism of action and efficacy against resistant strains. *Rifampin* - Rifampin inhibits **DNA-dependent RNA polymerase**, preventing bacterial RNA synthesis. - While a first-line agent, resistance to rifampin is a defining characteristic of **MDR-TB**, making it inappropriate for this specific scenario. *Isoniazid* - Isoniazid is a **prodrug** that inhibits the synthesis of **mycolic acid**, an essential component of the mycobacterial cell wall. - Resistance to isoniazid is also a key component of **MDR-TB**, rendering it ineffective for this patient. *Ethambutol* - Ethambutol inhibits **arabinosyl transferase**, an enzyme involved in the synthesis of the mycobacterial **cell wall**. - Although it is part of the first-line regimen, it is not an ATP synthase inhibitor, and resistance can develop, which would not address the MDR nature of the infection.

Q: What is the primary mechanism of action of the antifungal drug amphotericin B?

Binding to ergosterol in fungal cell membranes. ***Binding to ergosterol in fungal cell membranes*** - **Amphotericin B** is a **polyene antifungal** that binds specifically to **ergosterol**, a sterol found in fungal cell membranes. - This binding creates **pores** and **channels** in the membrane, leading to increased permeability, leakage of intracellular components, and ultimately **fungal cell death**. *Inhibition of cell wall synthesis* - This mechanism is characteristic of antifungal drugs like **echinocandins** (e.g., caspofungin), which target **β-(1,3)-D-glucan synthesis**. - Amphotericin B does not affect the fungal cell wall, but rather acts on the cell membrane. *Inhibition of nucleic acid synthesis* - This mechanism is primarily associated with antifungals like **flucytosine**, which is converted into a cytotoxic metabolite that interferes with DNA and RNA synthesis. - Amphotericin B does not directly inhibit the synthesis of genetic material. *Inhibition of protein synthesis* - While some **antibiotics** (e.g., tetracyclines, aminoglycosides) target bacterial protein synthesis, this is not a primary mechanism of action for antifungal drugs. - Antifungals generally act on unique fungal structures or metabolic pathways.

Q: Which antifungal agent is considered the most effective for treating invasive mucormycosis in immunocompromised patients?

Amphotericin B. ***Amphotericin B*** - **Amphotericin B**, particularly its lipid formulations, is considered the **first-line and most effective antifungal agent** for the treatment of invasive mucormycosis due to its broad spectrum of activity against Mucorales. - It works by binding to **ergosterol** in the fungal cell membrane, leading to pore formation and cell death, which is critical for rapidly progressive infections like mucormycosis. *Voriconazole* - **Voriconazole** is highly effective against *Aspergillus* and *Candida* species but has **minimal or no activity** against the **Mucorales** fungi that cause mucormycosis. - Using voriconazole for mucormycosis could lead to treatment failure and progression of the disease due to its **lack of efficacy** against this specific fungal group. *Fluconazole* - **Fluconazole** is a narrow-spectrum azole primarily used for *Candida* infections, particularly *Candida albicans*, and has **no activity** against **Mucorales** species. - Therefore, it is completely **ineffective** for treating invasive mucormycosis and should not be used. *Itraconazole* - While **itraconazole** has a broader spectrum than fluconazole and some activity against certain molds, it has **limited or unreliable activity** against **Mucorales** and is not recommended for invasive mucormycosis. - Its **pharmacokinetic profile** and drug interactions also make it less suitable as a primary agent for severe, life-threatening infections like mucormycosis compared to amphotericin B.

Q: A patient with a history of genital herpes presents with a new cluster of vesicles on the labia. Which medication is the most appropriate for the treatment of this condition?

Valacyclovir. ***Valacyclovir*** - It is a **prodrug of acyclovir** with improved oral bioavailability (54% vs 15-20%), allowing for less frequent dosing (typically twice daily) and better patient adherence. - **Valacyclovir** is highly effective in treating recurrent **genital herpes infections**, reducing the duration and severity of outbreaks by 1-2 days when started early. - **Most convenient dosing regimen** for suppressive therapy (500 mg once daily) makes it a preferred choice in clinical practice. *Incorrect: Acyclovir* - While effective for **genital herpes** and the original drug for HSV treatment, it has lower oral bioavailability (15-20%) compared to valacyclovir. - Requires **more frequent dosing** (200 mg five times daily or 400 mg three times daily for acute outbreaks), which can lead to reduced patient adherence. - Still an acceptable alternative, especially where cost is a consideration. *Incorrect: Famciclovir* - Famciclovir is a **prodrug of penciclovir** and is also effective for HSV infections with good bioavailability (77%). - Dosing is typically **250 mg three times daily** for acute outbreaks or 250 mg twice daily for suppression. - Clinically equivalent efficacy to valacyclovir, but slightly less convenient dosing schedule makes valacyclovir marginally preferred. *Incorrect: Ganciclovir* - Ganciclovir is primarily indicated for **cytomegalovirus (CMV) infections**, particularly in immunocompromised patients. - **Not recommended as first-line therapy** for HSV infections due to significant toxicity (bone marrow suppression) and the availability of safer, more effective alternatives. - Reserved for severe, acyclovir-resistant HSV cases in immunocompromised patients.

Q: Which of the following antibiotics is classified as a macrolide and is used for respiratory tract infections due to its effective activity against atypical bacteria?

Azithromycin. ***Azithromycin*** - Azithromycin is a **macrolide antibiotic** known for its excellent activity against **atypical bacteria** such as *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae*, and *Legionella pneumophila*, which are common causes of respiratory tract infections. - Its **long half-life** allows for once-daily dosing and shorter courses of therapy, making it a preferred choice for community-acquired pneumonia and other respiratory infections. *Ceftriaxone* - Ceftriaxone is a **third-generation cephalosporin antibiotic**, not a macrolide, primarily targeting **gram-positive** and **gram-negative bacteria**. - While effective against many respiratory pathogens, it has **limited activity against atypical bacteria**, unlike macrolides. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone antibiotic**, not a macrolide, with a broad spectrum of activity against **gram-negative bacteria** and some **atypical bacteria**. - While effective for some respiratory infections, its mechanism of action and classification differ significantly from macrolides. *Vancomycin* - Vancomycin is a **glycopeptide antibiotic** primarily used for **serious gram-positive infections**, particularly those caused by **methicillin-resistant *Staphylococcus aureus* (MRSA)**. - It is **not effective against atypical bacteria** and is generally reserved for more severe or resistant infections, not typically first-line for common respiratory tract infections.

Q: Anaerobes are resistant intrinsically against which of the following?

Aminoglycosides. ***Aminoglycosides*** - **Aminoglycosides** require an **oxygen-dependent transport system** to enter bacterial cells. [3] - Since **anaerobes** thrive in low-oxygen environments, this transport system is inactive, making them intrinsically resistant to aminoglycosides. [3] *Azithromycin* - **Azithromycin** (a macrolide) inhibits protein synthesis by binding to the 50S ribosomal subunit. - Many anaerobes are susceptible to **azithromycin**, making it an effective treatment for certain anaerobic infections. *Metronidazole* - **Metronidazole** is a potent prodrug that requires reduction by **anaerobic metabolism** to become active. [1], [2] - Its mechanism of action involves creating **cytotoxic free radicals** that damage DNA, making it highly effective against most anaerobes. [2] *Beta lactam antibiotics* - **Beta-lactam antibiotics**, such as **penicillins** and **cephalosporins**, interfere with bacterial cell wall synthesis. - While some anaerobes are susceptible, others have developed resistance mechanisms like producing **beta-lactamase enzymes**, but they are not intrinsically resistant across the board. [4]

Q: Which of the following is most active against slowly dividing tubercular bacilli ?

Rifampicin. ***Rifampicin*** - **Rifampicin** is highly effective against both rapidly and **slowly metabolizing** populations of *Mycobacterium tuberculosis*, including **persister bacilli** within macrophages and caseous lesions. - Its ability to penetrate host cells and kill semi-dormant organisms makes it crucial for shortening treatment duration and preventing relapse. - Among the given options, it has the **best sterilizing activity** against slow-growing tubercular populations. *Isoniazid* - **Isoniazid (INH)** is primarily bactericidal against **rapidly dividing** *Mycobacterium tuberculosis* but has limited activity against slowly dividing or dormant bacilli. - It targets mycolic acid synthesis, which is essential for rapidly growing cells but less critical for metabolically inactive cells. *Streptomycin* - **Streptomycin** primarily targets **rapidly multiplying** extracellular bacilli and has poor activity against intracellular or slowly dividing organisms. - Its action is dependent on active protein synthesis, which is significantly reduced in dormant states. *Ethambutol* - **Ethambutol** is mainly **bacteriostatic** and active against multiplying bacilli, preventing mycobacterial cell wall formation. - It is less effective against dormant or slowly replicating bacteria within caseous lesions.

Q: Mechanism of action of Niclosamide is:

Inhibition of mitochondrial oxidative phosphorylation. ***Inhibition of mitochondrial oxidative phosphorylation*** - **Niclosamide** is an **uncoupler of oxidative phosphorylation**, leading to **ATP depletion** in the parasite. - This effectively starves the parasite of energy, particularly **tapeworms**, which are highly dependent on this pathway. *Inhibition of substrate level phosphorylation* - **Substrate-level phosphorylation** is a metabolic pathway that directly phosphorylates ADP to ATP using high-energy intermediate molecules, not the primary target of niclosamide. - While it contributes to ATP production, its inhibition is not the primary mechanism of action for **niclosamide**. *Inhibition of proton efflux pumps* - **Proton efflux pumps** (e.g., proton pumps in gastric cells) are generally not the direct target for anthelmintic drugs like niclosamide. - This mechanism is characteristic of drugs like **proton pump inhibitors** (PPIs) used to reduce stomach acid. *Increase production of free radicals* - Some antiparasitic drugs act by increasing **oxidative stress** and **free radical production**, leading to parasite death. - However, for **niclosamide**, the primary mechanism is the disruption of **ATP synthesis** through uncoupling.

Q: Which is the fastest acting anti-malarial drug?

Artether. ***Artether*** - **Artether** is an artemisinin derivative known for its rapid action due to its ability to quickly reduce **parasite biomass**. - It works by producing **free radicals** that damage parasite proteins and membranes, leading to rapid parasitic clearance. *Chloroquine* - **Chloroquine** is a 4-aminoquinoline that works by inhibiting **heme detoxification** in the parasite, but its action is slower compared to artemisinins. - Due to widespread resistance, its efficacy is limited in many regions. *Quinine* - **Quinine** is an alkaloid with proven efficacy and acts by interfering with the parasite's **heme polymerization**. - While effective, its onset of action is not as rapid as that of artemisinin derivatives. *Mefloquine* - **Mefloquine** is a quinoline-methanol derivative used for malaria treatment and prophylaxis. - It has a long half-life and is effective, but its action is slower and it is not considered a rapid-acting drug.

Question 1

A patient with a severe penicillin allergy requires treatment for syphilis. Which alternative antibiotic should be considered?

Accepted Answer

Doxycycline

Answer

Amoxicillin

Answer

Ceftriaxone

Answer

Vancomycin

Question 2

A patient presents with multidrug-resistant tuberculosis. Which drug, acting as an ATP synthase inhibitor, would be the most appropriate for treatment?

Accepted Answer

Bedaquiline

Answer

Rifampin

Answer

Isoniazid

Answer

Ethambutol

Question 3

What is the primary mechanism of action of the antifungal drug amphotericin B?

Accepted Answer

Binding to ergosterol in fungal cell membranes

Answer

Inhibition of cell wall synthesis

Answer

Inhibition of nucleic acid synthesis

Answer

Inhibition of protein synthesis

Question 4

Which antifungal agent is considered the most effective for treating invasive mucormycosis in immunocompromised patients?

Accepted Answer

Amphotericin B

Answer

Voriconazole

Answer

Fluconazole

Answer

Itraconazole

Question 5

A patient with a history of genital herpes presents with a new cluster of vesicles on the labia. Which medication is the most appropriate for the treatment of this condition?

Accepted Answer

Valacyclovir

Answer

Acyclovir

Answer

Famciclovir

Answer

Ganciclovir

Question 6

Which of the following antibiotics is classified as a macrolide and is used for respiratory tract infections due to its effective activity against atypical bacteria?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Ciprofloxacin

Answer

Vancomycin

Question 7

Anaerobes are resistant intrinsically against which of the following?

Accepted Answer

Aminoglycosides

Answer

Azithromycin

Answer

Metronidazole

Answer

Beta lactam antibiotics

Question 8

Which of the following is most active against slowly dividing tubercular bacilli ?

Accepted Answer

Rifampicin

Answer

Isoniazid

Answer

Streptomycin

Answer

Ethambutol

Question 9

Mechanism of action of Niclosamide is:

Accepted Answer

Inhibition of mitochondrial oxidative phosphorylation

Answer

Inhibition of substrate level phosphorylation

Answer

Inhibition of proton efflux pumps

Answer

Increase production of free radicals

Question 10

Which is the fastest acting anti-malarial drug?

Accepted Answer

Artether

Answer

Chloroquine

Answer

Quinine

Answer

Mefloquine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?